Stocks Hitting 52-Week Lows

Opexa Therapeutics Inc OPXA shares fell 64.4 percent to touch a new 52-week low of $1.25 after the company disclosed that its top-line results from Phase 2b Abili-T trial evaluating Tcelna did not meet primary endpoint.
Novo Nordisk A/S (ADR) NVO shares dropped 14.7 percent to touch a new 52-week low of $34.92 after the company issued a warning on profit forecast for the full year. The company indicated its sales forecast are around 5-6 percent for the full year, while adjusted operating profit is guided between 5-7 percent in local currencies.
McKesson Corporation MCK shares reached a new 52-week low of $116.71 after the company reported downbeat earnings for its second quarter and lowered its FY17 earnings outlook.
StoneMor Partners L.P. STON shares declined 43 percent to touch a new 52-week low of $14.16 after the company reported a temporary reduction in its quarterly cash distribution and issued a partnership update. Wunderlich downgraded StoneMor Partners from Buy to Hold.